trending Market Intelligence /marketintelligence/en/news-insights/trending/bncoifdzp0q3k4paxrsphq2 content esgSubNav
In This List

Nemus Bioscience closes $1.8M private placement

Case Study

Identifying PPE Suppliers During the Pandemic


Highlighting the Top Regional Aftermarket Research Brokers by Sector Coverage


COVID-19 Impact & Recovery: Healthcare Outlook for H2 2021


Corporate Credit Risk Trends in Developing Markets: A Loss Given Default (LGD) Perspective

Nemus Bioscience closes $1.8M private placement

Nemus Bioscience Inc. received about $1.8 million in the final closing of a private placement with Emerald Health Sciences Inc.

Emerald Health bought 15 million ordinary Nemus shares and warrants to buy an additional 20.4 million shares at 10 cents apiece.

On a fully converted basis, Emerald holds a majority of Nemus' outstanding share capital.

Costa Mesa, Calif.-based Nemus intends to use proceeds for working capital and to explore potential strategic opportunities.

Emerald Health and Nemus are focused on cannabinoid-based therapeutics.